These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10860230)

  • 21. More than just hype.
    Sigal RJ
    CMAJ; 2003 Jun; 168(13):1647; author reply 1647-8. PubMed ID: 12821615
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ
    Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should you take an ACE inhibitor?
    Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):1-2. PubMed ID: 10740441
    [No Abstract]   [Full Text] [Related]  

  • 24. [Further options with ramipril. Besides cardio- and nephro-protection diabetes prevention, too?].
    MMW Fortschr Med; 2003 Sep; 145(39):47. PubMed ID: 14649075
    [No Abstract]   [Full Text] [Related]  

  • 25. From Tritace to Tri-Plen - the South African journey.
    Cardiovasc J Afr; 2009; 20(1):69-70. PubMed ID: 19287820
    [No Abstract]   [Full Text] [Related]  

  • 26. [The HOPE Study. What does it contribute to general practice?].
    Mann J; Sleight P
    MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and cardiovascular risk in the HOPE study.
    Taylor R
    Lancet; 2002 Jun; 359(9323):2117-8; author reply 2118. PubMed ID: 12086795
    [No Abstract]   [Full Text] [Related]  

  • 28. [Added organ protection at little cost. Double savings with ACE inhibitors].
    MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725008
    [No Abstract]   [Full Text] [Related]  

  • 29. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomic impact of HOPE.
    Ostergren JB; Björholt I; Andersson F; Kahan T
    Int J Clin Pract Suppl; 2001 Jan; (117):19-21. PubMed ID: 11715354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation.
    Kleinert S
    Lancet; 1999 Sep; 354(9181):841. PubMed ID: 10485736
    [No Abstract]   [Full Text] [Related]  

  • 33. Ask the doctor. Recently, I read that the ACE inhibitor ramipril is very good at preventing heart problems, particularly in people with diabetes. I'm diabetic, and for years I have been on a different ACE inhibitor (lisinopril). Should I be taking ramipril instead?
    Lee TH
    Harv Heart Lett; 2001 Apr; 11(8):7-8. PubMed ID: 11343399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Training for LCA (Hope study)].
    Gueyffier F
    Rev Prat; 2012 May; 62(5):687-9. PubMed ID: 22730805
    [No Abstract]   [Full Text] [Related]  

  • 35. The HOPE study and diabetes. Heart Outcomes Prevention Evaluation.
    Fegan G; Ward D; Clarke L; MacLeod K; Hattersley A
    Lancet; 2000 Apr; 355(9210):1182-3; author reply 1183-4. PubMed ID: 10791400
    [No Abstract]   [Full Text] [Related]  

  • 36. The HOPE study and diabetes. Heart Outcomes Prevention Evaluation.
    Webster MW
    Lancet; 2000 Apr; 355(9210):1181-2; author reply 1183-4. PubMed ID: 10791398
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance--is there still hope?
    Ingelfinger JR; Solomon CG
    N Engl J Med; 2006 Oct; 355(15):1608-10. PubMed ID: 16980381
    [No Abstract]   [Full Text] [Related]  

  • 38. The HOPE study and diabetes. Heart Outcomes Prevention Evaluation.
    Lewis V; Kloer P; Prasad N; Alcolado JC
    Lancet; 2000 Apr; 355(9210):1182; author reply 1183-4. PubMed ID: 10791399
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ramipril can do more. Halting progression of atherosclerosis].
    MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530
    [No Abstract]   [Full Text] [Related]  

  • 40. Should the results of the HOPE study affect nephrological practice? For the HOPE investigators.
    Mann JF
    Nephrol Dial Transplant; 2000 Apr; 15(4):453-4. PubMed ID: 10727536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.